John Sourbeer
Stock Analyst at UBS
(3.43)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QGEN Qiagen | Maintains: Neutral | 48 50 | 45.29 | 10.4% | 5 | Aug 7, 2025 | |
WST West Pharmaceutical ... | Maintains: Strong Buy | 285 320 | 253.5 | 26.23% | 4 | Jul 25, 2025 | |
ICLR Icon | Maintains: Strong Buy | 170 240 | 175 | 37.14% | 2 | Jul 25, 2025 | |
CYRX CryoPort | Maintains: Strong Buy | 10 11 | 8.64 | 27.31% | 6 | Apr 1, 2025 | |
STVN Stevanato Group | Maintains: Neutral | 24 24 | 26.43 | -11.09% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 43 45 | 28.57 | 57.51% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 2 | 1.17 | 70.94% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 133 145 | 95.12 | 52.44% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 15 | 20.01 | -25.04% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 452 480 | 490.64 | -2.17% | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 8 | 1.29 | 481.4% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 94 102 | 30.91 | 229.99% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 64 | 63.48 | 0.03% | 6 | Feb 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 50 | 12.64 | 295.57% | 1 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | 42.98 | 58.21% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 142 128 | 133.77 | -4.31% | 2 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 4 | 2.43 | 64.61% | 2 | Mar 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | 17.63 | 30.46% | 1 | Feb 22, 2021 |